awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39683930-2F5AB3D6-676A-43FB-A4FC-2151AFF67023
Q39683930-2F5AB3D6-676A-43FB-A4FC-2151AFF67023
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39683930-2F5AB3D6-676A-43FB-A4FC-2151AFF67023
Cyclooxygenase-2 inhibitors and cardiovascular risk in a nation-wide cohort study after the withdrawal of rofecoxib.
P50
Q39683930-2F5AB3D6-676A-43FB-A4FC-2151AFF67023
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39683930-2F5AB3D6-676A-43FB-A4FC-2151AFF67023
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
42c4be8c02c8e7b0d79a8cdc50e6be33c81783f1
P1545
3
http://www.w3.org/2001/XMLSchema#string
P1932
Erik Ingelsson
http://www.w3.org/2001/XMLSchema#string
P50
Erik Ingelsson